HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Differential expression of transthyretin in papillary tumors of the endolymphatic sac and choroid plexus.

Abstract
Aggressive papillary tumors of the temporal bone, occurring sporadically or as part of von Hippel-Lindau disease, have been shown to originate within the endolymphatic sac or duct. Also implicated as a potential precursor from which some of these tumors may arise is ectopic choroid plexus epithelium. To aid in the differentiation between papillary tumors of endolymphatic sac and duct origin and those arising from choroid plexus, an immunohistochemical study using stains for transthyretin (TTR), cytokeratins, S-100 protein, epithelial membrane antigen (EMA), and glial fibrillary acidic protein (GFAP) was carried out on archival specimens of normal and neoplastic endolymphatic sac and duct and choroid plexus epithelium. Transthyretin, a marker for choroid plexus epithelium, was found to show differential expression between choroid plexus papillomas and aggressive papillary tumors of the endolymphatic sac or duct. Therefore the use of TTR in concert with other immunohistochemical stains appear to aid in the differentiation between intracranial and intratemporal papillary tumors arising from choroid plexus and endolymphatic sac or duct epithelium.
AuthorsC A Megerian, B Z Pilch, A K Bhan, M J McKenna
JournalThe Laryngoscope (Laryngoscope) Vol. 107 Issue 2 Pg. 216-21 (Feb 1997) ISSN: 0023-852X [Print] United States
PMID9023246 (Publication Type: Journal Article)
Chemical References
  • Antigens, Neoplasm
  • Biomarkers
  • Prealbumin
Topics
  • Adenoma (metabolism, pathology)
  • Antigens, Neoplasm (analysis)
  • Biomarkers (analysis)
  • Bone Neoplasms (metabolism, pathology)
  • Choroid Plexus Neoplasms (metabolism, pathology)
  • Endolymphatic Sac (immunology)
  • Glioma (metabolism, pathology)
  • Humans
  • Immunohistochemistry
  • Papilloma (metabolism, pathology)
  • Prealbumin (biosynthesis)
  • Vestibular Diseases (immunology, metabolism, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: